9-101371346-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001701.4(BAAT):c.59G>A(p.Arg20Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.666 in 1,613,430 control chromosomes in the GnomAD database, including 360,951 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001701.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAAT | NM_001701.4 | c.59G>A | p.Arg20Gln | missense_variant | 2/4 | ENST00000259407.7 | NP_001692.1 | |
BAAT | NM_001127610.2 | c.59G>A | p.Arg20Gln | missense_variant | 2/4 | NP_001121082.1 | ||
BAAT | NM_001374715.1 | c.59G>A | p.Arg20Gln | missense_variant | 2/4 | NP_001361644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAAT | ENST00000259407.7 | c.59G>A | p.Arg20Gln | missense_variant | 2/4 | 1 | NM_001701.4 | ENSP00000259407.2 |
Frequencies
GnomAD3 genomes AF: 0.630 AC: 95635AN: 151856Hom.: 30765 Cov.: 31
GnomAD3 exomes AF: 0.647 AC: 162237AN: 250776Hom.: 53442 AF XY: 0.644 AC XY: 87332AN XY: 135540
GnomAD4 exome AF: 0.669 AC: 978399AN: 1461454Hom.: 330172 Cov.: 72 AF XY: 0.666 AC XY: 484192AN XY: 727044
GnomAD4 genome AF: 0.630 AC: 95676AN: 151976Hom.: 30779 Cov.: 31 AF XY: 0.630 AC XY: 46759AN XY: 74258
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 15, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Hypercholanemia, familial 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Bile acid conjugation defect 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at